Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Midkine links aging with breast cancer-A new predictor of cancer risk. | Cancer Cell | 2024 | 39366374 | PubTator, text mining | PubMed |
| UCHL1 Overexpression Is Related to the Aggressive Phenotype of Non-small Cell Lung Cancer. | Tuberc Respir Dis (Seoul) | 2024 | 39362830 | PubTator, text mining | PubMed |
| Diagnostic value of Midkine and AFP in the detection of hepatocellular carcinoma: A systematic review and meta-analysis. | Caspian J Intern Med | 2024 | 39359432 | PubTator, text mining | PubMed |
| The estrogen response in fibroblasts promotes ovarian metastases of gastric cancer. | Nat Commun | 2024 | 39349474 | PubTator, text mining | PubMed |
| Analytical Validation of Cxbladder® Detect, Triage, and Monitor: Assays for Detection and Management of Urothelial Carcinoma. | Diagnostics (Basel) | 2024 | 39335740 | PubTator, text mining | PubMed |
| Identification of Key Genes in Fetal Gut Development at Single-Cell Level by Exploiting Machine Learning Techniques. | Proteomics | 2024 | 39324223 | PubTator, text mining | PubMed |
| BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesothelioma. | Cancer Gene Ther | 2024 | 39300217 | PubTator, text mining | PubMed |
| Immune escape between endoplasmic reticulum stress-related cancer cells and exhausted CD8+T cells leads to neoadjuvant chemotherapy resistance in ovarian cancer. | Biochem Biophys Res Commun | 2024 | 39278093 | PubTator, text mining | PubMed |
| Midkine: A Cancer Biomarker Candidate and Innovative Therapeutic Approaches. | Eur J Breast Health | 2024 | 39257008 | PubTator, text mining | PubMed |
| Machine learning approach to predict blood-secretory proteins and potential biomarkers for liver cancer using omics data. | J Proteomics | 2024 | 39216516 | PubTator, text mining | PubMed |
| Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR-Cas gene editing. | Nat Nanotechnol | 2024 | 39209994 | PubTator, text mining | PubMed |
| Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer. | Cancer Genomics Proteomics | 2024 | 39191496 | PubTator, text mining | PubMed |
| Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer's disease. | Cell Rep Med | 2024 | 39127040 | PubTator, text mining | PubMed |
| The effect of rs2910686 on ERAP2 expression in IBD and epithelial inflammatory response. | J Transl Med | 2024 | 39123229 | PubTator, text mining | PubMed |
| Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC. | Cell Rep | 2024 | 39116206 | PubTator, text mining | PubMed |
| MDK promotes M2 macrophage polarization to remodel the tumour microenvironment in clear cell renal cell carcinoma. | Sci Rep | 2024 | 39107475 | PubTator, text mining | PubMed |
| Over-expression of KRT17 and MDK genes at mRNA levels in urine-exfoliated cells is associated with early non-invasive diagnosis of non-muscle-invasive bladder cancer. | Clin Biochem | 2024 | 39069115 | PubTator, text mining | PubMed |
| RNA Interference based Midkine Gene Therapy for Hepatocellular Carcinoma. | Asian Pac J Cancer Prev | 2024 | 39068570 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing uncovers cellular heterogeneity and the progression of heterotopic ossification of the elbow. | Front Pharmacol | 2024 | 39045052 | PubTator, text mining | PubMed |
| Relationship between serum Midkine and Omentin-1 levels and the severity of sepsis in patients and their prognostic value. | Libyan J Med | 2024 | 39042809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=14